参考文献

1.杨冬梓，石一复．小儿和青春期妇科学．北京：人民卫生出版社，2003.

2.罗奕巾．青春期异常子宫出血诊治临床探讨．中国医药科学，2016(02): 78-80.

3.Fraser IS, Critchley HO, Broder M. et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med, 2011(29): 383-390.

4.郎景和等．异常子宫出血诊断与治疗指南．中华妇产科杂志，2014(49): 801-806.

5.Gardner FJ, Konje JC, Bell SC, et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long. term follow-up of a randomised control trial. Gynecol Oncol, 2009(114): 452-456.

6.Fabres C, Aviles G, De La Jara C, et al. The cesarean delivery scar pouch: clinical implications and diagnostic correlation between transvaginal sonography and hysteroscopy. J Ultrasound Med, 2003(7): 695-700, 701-702.

7.Salim S, Won H, Nesbitt-Hawes E. et al. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol, 2011(18): 569-581.

8.王春庆，田秦杰．FIGO关于育龄期异常子宫出血的病因分类．生殖医学杂志，2013(22): 963-966.

9.Weiss G, Maseelall P, Schott LL, et al. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women'S Health Across the Nation(SWAN).Fertil Steril, 2009(91): 201-206.

10.中华医学会妇产科学分会妇科内分泌学组．异常子宫出血诊断与治疗指南．中华妇产科杂志，2014(49):801-808.

11.覃晓．子宫内膜息肉诊治进展．广西医科大学学报，2015(6): 1022-1024.

12.FIGO异常子宫出血PALM-COEIN诊治指南．

13.Fraser IS, Critchley HO, Broder M. et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med, 2011, 29: 383-390.

14.RCOG, BSGE.2016 RCOG/BSGEJoint Guideline: Management of Endometrial Hyperplasia. Green-top guideline, 2016(67).

15.韩学军．皮下埋植避孕技术进展．中国实用妇科与产科杂志，2001, 17: 518-521.

16.Department of Reproductive Health and Research. WHO.避孕方法选用的医学标准．国家人口计生委科学技术研究所(译).(第4版).北京：中国人口出版社，2011.

17.Taneepanichskul S, Reinprayoon D, Thaithumyanon P, et al. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception, 2006(73): 368-371.

18.Blumenthal PD, Gemzell, Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of Implanon. Eur J Contracept Reprod Health Care, 2008(13 Suppl l): 29-36.

19.Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med, 2011(29): 383-390.

20.中华医学会妇产科学分会妇科内分泌学组．异常子宫出血诊断与治疗指南．中华妇产科杂志，2014(11):801-806.

21.Diedrich JT, Desai S, Zhao Q, et al. Association of shortterm bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol, 2015(212): 50.

22.Winner B, Peipert JF, Zhao Q, et al. Effectiveness of longacting reversible contraception. N Engl J Med, 2012(366):1998-2007.

23.《皮下埋植避孕方法临床应用专家共识》编写组，皮下埋植避孕方法临床应用专家共识．中华妇产科杂志，2013(48): 476-480.

24.楚素伟，郎玉萍．左炔诺孕酮宫内缓释系统临床应用研究．国际生殖健康/计划生育杂志，2009(5): 317-319.

25.尚思慧，林琬君．左炔诺孕酮宫内缓释系统的非避孕应用．中国计划生育和妇产科，2011(6): 64-68.

26.中华医学会心血管病学分会，中国老年学学会心脑血管病专业委员会．华法林抗凝治疗中国专家共识．中华内科杂志，2013(1): 76-82.

27.ASTH, Australasian Society of Thrombosis and Haemostasis. An update of consensus guidelines for warfarin reversal. Med J Aust, 2013(4): 198-199.

28.AAOM Clinical Practice Statement: Subject: Management of Patients on Warfarin Therapy. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016.

29.中华医学会妇产科学分会妇科内分泌学组．异常子宫出血诊断与治疗指南．中华妇产科杂志，2014(11):801-806.